<?xml version="1.0" encoding="UTF-8"?>
<p>Lad et al. reported the synthesis of a series of methylsulfonyl benzothiazoles, obtained from 5-ethoxybenzothiazol-2-amine which were tested their anticancer activities. Among these derivatives, the nitrophenyl sulphonamide based methylsulfonyl benzothiazole 
 <bold>38</bold> (
 <xref ref-type="fig" rid="F0023">Figure 23</xref>) and 
 <italic>ter</italic>-butyl sulphonamide based methylsulfonyl benzothiazole 
 <bold>39</bold> (
 <xref ref-type="fig" rid="F0023">Figure 23</xref>) exhibited the best anticancer activities against HeLa cell line with the IG
 <sub>50</sub> value of 0.22 µM and 0.6 µM respectively
 <xref rid="CIT0044" ref-type="bibr">
  <sup>44</sup>
 </xref>.
</p>
